Key points are not available for this paper at this time.
The basal-like and erbB2+ subtypes of breast cancer are more sensitive to paclitaxel- and doxorubicin-containing preoperative chemotherapy than the luminal and normal-like cancers.
Rouzier et al. (Mon,) studied this question.